The Role of mTOR in Amyotrophic Lateral Sclerosis

Area of Science:

• Neuroscience
• Metabolic Signaling
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease linked to protein aggregates, mitochondrial dysfunction, and impaired homeostasis.
• Mammalian target of rapamycin (mTOR) signaling is crucial for cellular homeostasis, regulating autophagy, energy metabolism, and neuronal plasticity.
• Dysregulation of mTOR pathways is increasingly implicated in ALS pathophysiology.

Purpose of the Study:

• To review the regulatory roles of mTOR signaling pathways in ALS.
• To examine the interaction of mTOR with other metabolic pathways relevant to ALS.
• To assess the potential of mTOR modulation for treating ALS progression.

Main Methods:

• Literature review of recent studies on mTOR signaling and ALS.
• Analysis of the role of metabolic pathways in neuromuscular junction dysfunction.
• Exploration of neurocentric and peripheral mechanisms in ALS.

Main Results:

• mTOR signaling influences cellular processes critical for neuronal survival and function.
• Metabolic pathways regulated by mTOR impact the neuromuscular junction, contributing to ALS symptoms.
• Evidence suggests a connection between mTOR and neuromuscular dysfunction in ALS.

Conclusions:

• mTOR signaling pathways represent a promising therapeutic target for ALS.
• Interactions between mTOR and other metabolic routes offer potential biomarkers for ALS.
• Modulating mTOR may help manage muscle weakness and atrophy in ALS patients.